Ontology highlight
ABSTRACT:
SUBMITTER: Beeh KM
PROVIDER: S-EPMC5077727 | biostudies-literature | 2016 Oct
REPOSITORIES: biostudies-literature
Tuberculosis and respiratory diseases 20161005 4
Bronchodilators are the cornerstone of symptomatic chronic obstructive pulmonary disease (COPD) treatment. They are routinely recommended for symptom reduction, with a preference of long-acting over short-acting drugs. Bronchodilators are classified into two classes based on distinct modes of action, i.e., long-acting antimuscarinics (LAMA, once-daily and twice-daily), and long-acting β2-agonists (LABA, once-daily and twice-daily). In contrast to asthma management, evidence supports the efficacy ...[more]